3 Min Read
JOHANNESBURG (Reuters) - Days before coronavirus vaccinations start in South Africa, medical schemes have still not agreed how and to what extent they will contribute to the cost of inoculations for people without insurance cover, industry executives told Reuters. A test tube labelled vaccine in front of an AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
South Africa is expecting its first 1 million doses of the AstraZeneca vaccine to land on Monday and will start immunising health workers from mid-February. The country has been the hardest-hit by the COVID-19 pandemic on the continent, with more than 1.4 million cases and over 43,000 deaths to date.